| Identification | Back Directory | [Name]
Bromoacetamido-PEG5 -Azide | [CAS]
1415800-37-1 | [Synonyms]
Bromoacetamido-PEG5-N3
Bromoacetamide-PEG5-azide
Bromoacetamido-PEG5 -Azide
N-(2-[2-(2-(2-[2-(2-Azidoethoxy)ethoxy]ethoxy)ethoxy)ethoxy]ethyl)-2-bromoacetamide | [Molecular Formula]
C14H27BrN4O6 | [MDL Number]
MFCD22683281 | [MOL File]
1415800-37-1.mol | [Molecular Weight]
427.3 |
| Hazard Information | Back Directory | [Description]
Bromoacetamido-PEG5-azide is a heterobifunctional crosslinking reagent. The bromide (Br) is a very good leaving group for nucleophilic substitution. The azide group can react with alkyne, BCN, DBCO via Click Chemistry to yield a stable triazole linkage. PEG spacer increases solubility in aqueous media. | [Uses]
Bromoacetamido-PEG5-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Bromoacetamido-PEG5-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups. | [IC 50]
PEGs | [References]
[1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
|
|